Citation: P. Zimmet, Globalization, coca-colonization and the chronic disease epidemic: can theDoomsday scenario be averted? (Reprinted from Journal of Internal Medicine, vol 247, pg 301-310, 2000), J INTERN M, 249, 2001, pp. 17-26
Authors:
Walder, K
McMillan, JS
Lee, S
Civitarese, A
Zimmet, P
Collier, GR
Citation: K. Walder et al., Effects of beacon administration on energy expenditure and substrate utilisation in Psammomys obesus (Israeli sand rats), INT J OBES, 25(9), 2001, pp. 1281-1285
Authors:
Steiner, G
Hamsten, A
Hosking, J
Stewart, D
McLaughlin, P
Gladstone, P
Sole, M
Syvanne, M
Hamsten, A
Camelon, K
Schloegl, G
Genest, J
Reeves, F
Savard, R
Letarte, A
Bellavance, N
Touchette, J
Latour, Y
Marchand, P
Rondeau, C
Rivard-Gervais, N
Belanger, A
Hamel, D
Dumas, R
Sandri, M
Morin, N
Caponi, E
Barbeau, C
Gauthier, S
Ooi, TC
Davies, RF
Braaten, JT
Baker, A
Favreau, C
Collar, C
Zinman, B
Gladstone, P
Aldridge, H
Donat, DJ
Tsui, E
Barnie, A
DiMonte, L
MacLean, S
Bond, M
Camelon, K
Martin, C
Zawacki, R
Dziuran, K
Gouveia, MR
Taskinen, MR
Nieminen, M
Nikkila, K
Virtanen, K
Makimattila, S
Malmstrom, R
Kohtamaki, H
Jamsen, P
Salo, A
Puupponen, M
Kesaniemi, A
Ikaheimo, M
Ukkola, O
Salmela, P
Savolainen, M
Huikuri, H
Airaksinen, J
Koistinen, J
Mannermaa, L
Ukkola, L
Ketonen, K
Silaste, ML
Salovaara, A
Efendic, S
Svane, B
Hellekant, C
Bavenholm, P
Karlen, A
Hadell, K
Hamsten, A
Franson, K
Mohlkert, D
Nordlander, R
Ehrenstig, L
Tan, MH
Title, LM
Johnstone, D
Winch, S
Higgins-Bowser, I
Shlossberg, A
Murdock, H
Elliott, T
Fung, A
Jalbert, A
Leung, S
Turnbull, S
Norman, E
Valensi, P
Farez, C
Tavolaro, O
Sachs, RN
Sedjari, F
Laakso, M
Kettunen, R
Eranen, J
Lehto, S
Raisanen, R
Jantunen, A
Valve, R
Toivanen, A
Frohlich, J
Vannetta, H
Bowden, F
Seccombe, DW
Ehnholm, C
Gref, CG
Ikonen, M
Sundvall, J
Seccombe, DW
McGuinness, C
Ho, A
Hamilton, J
Pritchard, H
McLaughlin, P
Gladstone, P
Allard, N
Bond, M
Bui, S
Van der Wal, H
Hosking, J
Davis, CE
Tyroler, HA
Stewart, D
Curtis, RC
Miles, M
Khaltaev, N
Sole, M
Kirkeeide, R
Frick, H
Hata, Y
Rifkind, B
Zimmet, P
Gent, M
Schonfeld, G
de Bono, D
Reeves, F
Carter, A
Ansquer, JC
Fraitag, B
Guivarc'h, PH
Irvine, A
Jacovella, J
Munoz, A
Rode, H
Yacine, A
Asmar-Kristiansen, D
Bonnefous, F
Belanger, F
Bond, M
Brown, M
DeLorme, L
Galos, C
Jenkins, R
Lanoue, C
Moussalli, R
Murtomaki, E
Zandomenighi, F
Citation: G. Steiner et al., Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study, LANCET, 357(9260), 2001, pp. 905-910
Citation: P. Zimmet, Globalization, coca-colonization and the chronic disease epidemic: can theDoomsday scenario be averted?, J INTERN M, 247(3), 2000, pp. 301-310
Authors:
Davis, TME
Zimmet, P
Davis, WA
Bruce, DG
Fida, S
Mackay, IR
Citation: Tme. Davis et al., Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study, DIABET MED, 17(9), 2000, pp. 667-674
Authors:
Donahue, RP
Zimmet, P
Bean, JA
Decourten, M
Donahue, RAD
Collier, G
Goldberg, RB
Prineas, RJ
Skyler, J
Schneiderman, N
Citation: Rp. Donahue et al., Cigarette smoking, alcohol use, and physical activity in relation to serumleptin levels in a multiethnic population: The Miami community health study, ANN EPIDEMI, 9(2), 1999, pp. 108-113
Authors:
Walder, K
Lewandowski, P
Morton, G
Sanigorski, A
de Silva, A
Zimmet, P
Collier, GR
Citation: K. Walder et al., Leptin resistance in a polygenic, hyperleptinemic animal model of obesity and NIDDM: Psammomys obesus, INT J OBES, 23(1), 1999, pp. 83-89
Authors:
Scott, R
Lintott, CJ
Zimmet, P
Campbell, L
Bowen, K
Welborn, T
Citation: R. Scott et al., Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus?, DIABET RE C, 43(3), 1999, pp. 179-185
Authors:
Donahue, RP
Prineas, RJ
Donahue, RD
Zimmet, P
Bean, JA
De Courten, M
Collier, G
Goldberg, RB
Skyler, JS
Schneiderman, N
Citation: Rp. Donahue et al., Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study, DIABET CARE, 22(7), 1999, pp. 1092-1096
Citation: P. Zimmet et G. Collier, Clinical efficacy of metformin against insulin resistance parameters - Sinking the iceberg, DRUGS, 58, 1999, pp. 21-28
Authors:
Beck-Nielsen, H
Skyler, J
Hanefeld, M
Eschwege, E
Finn, JR
DeFronzo, R
Del Prato, S
Bjorntorp, P
Groop, L
Haring, H
Zimmet, P
Riou, JP
Vague, P
Reaven, G
Bailey, CJ
Iselin, HU
Wiernsperger, N
Pugeat, M
Garber, A
Taskinen, MR
Laube, H
Yki-Jarvinen, H
Consoli, A
Harter, M
Lalau, JD
Charles, A
Citation: H. Beck-nielsen et al., Prevention of type 2 diabetes - Role of metformin - Discussion, DRUGS, 58, 1999, pp. 75-82
Authors:
Horton, V
Stratton, I
Bottazzo, GF
Shattock, M
Mackay, I
Zimmet, P
Manley, S
Holman, R
Turner, R
Citation: V. Horton et al., Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43), DIABETOLOG, 42(5), 1999, pp. 608-616